TABLE 2.
Distribution | Treatment | MFIa | Effluxb |
---|---|---|---|
% | |||
1 | 250 nm Bp (substrate) | 105 ± 66 | 100 |
2 | Bp + 10 μm FTC (inhibitor) | 546 ± 4 | 0 |
3 | Bp + 2 μm curcumin | 139 ± 60 | 92 ± 19 |
4 | Bp + 35 nm gA | 108 ± 71 | 99 ± 21 |
5 | Bp + 35 nm gA + 2 μm curcumin | 540 ± 2 | 1.3 ± 1 |
6 | Bp + 7.5 nm ouabain | 106 ± 42 | 100 ± 19 |
7 | Bp + 7.5 nm ouabain + 2 μm curcumin | 376 ± 32 | 38 ± 12 |
a Mean values of the mode (i.e. the most frequently measured fluorescence intensity) of each distribution ± standard deviation of the mean from two independent experiments.
b The difference in MFI values in the presence of 250 nm Bp alone to that in the presence of 250 nm Bp with 10 μm FTC was defined as 100% efflux activity.